Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Drugs@FDA (Enter "glatiramer acetate" in search box.)
Prediction of oxygen uptake during walking in ambulatory persons with multiple sclerosis.
Spectrum of nontraumatic myelopathies in Ethiopian patients: hospital-based retrospective study.
Correction: Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
Visualizing Non-Gaussian Diffusion: Clinical Application of q-Space Imaging and Diffusional Kurtosis Imaging of the Brain and Spine.
Monoclonal antibodies in MS: mechanisms of action.
Anti-JCV antibody levels in serum or plasma further define risk of natalizumab-associated PML.
Estrogen treatment in multiple sclerosis.
Newly onset sinus bradycardia in the context of multiple sclerosis relapse.
Treatment satisfaction in multiple sclerosis.
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis.
G protein-coupled receptor 37 is a negative regulator of oligodendrocyte differentiation and myelination.
Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound.
Identical lesion morphology in primary progressive and relapsing-remitting MS -an ultrahigh field MRI study.
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity.
The challenge of comorbidity in clinical trials for multiple sclerosis.
Oligodendrogenesis and myelinogenesis during postnatal development effect of glatiramer acetate.
Dimethylfumarate protects against TNF-α-induced secretion of inflammatory cytokines in human endothelial cells.
Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro.
Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROS.
[The effect of flupirtine, various analgesics and muscle relaxants on skeletal muscle tone in the conscious rat].
Individual oligodendrocytes have only a few hours in which to generate new myelin sheaths in vivo.
Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis.
Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.
Pages
« first
‹ previous
…
53
54
55
56
57
58
59
60
61
…
next ›
last »